the pharmacokinetics of a new potent vasodilator , 2- ( n-benzyl-n-methylamino ) -ethyl methyl 2,6-dimethyl-4- ( m-nitrophenyl ) -1,4-dihydropyridine-3,5-dicarboxylate hydrochloride ( nicardipine hydrochloride ) , were studied after oral and i.v . dosage to rats , dogs , monkeys and humans .
C0012315
dihydropyridine
C0770150
nicardipine hydrochloride